BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Sarcomas AND TRIM27, DASS-46L4_6, RFP, 5987, ENSG00000234495, RNF76 AND Clinical Outcome
267 results:

  • 1. Post-surgical ctDNA-based molecular residual disease detection in patients with stage I uterine malignancies.
    Recio F; Scalise CB; Loar P; Lumish M; Berman T; Peddada A; Kalashnikova E; Rivero-Hinojosa S; Beisch T; Nicosia B; Farmer T; Dutta P; Malhotra M; ElNaggar AC; Liu MC; Vaccarello L; Holloway RW
    Gynecol Oncol; 2024 Mar; 182():63-69. PubMed ID: 38262240
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. sarcomas With RAD51B Fusions Are Associated With a Heterogeneous Phenotype.
    Chang HY; Dermawan J; Sharma A; Dickson B; Turashvili G; Torrence D; Nucci M; Chiang S; Oliva E; Kirchner M; Stenzinger A; Mechtersheimer G; Antonescu C
    Mod Pathol; 2024 Feb; 37(2):100402. PubMed ID: 38141829
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. clinical outcomes of Intensity-modulated Carbon-ion Radiotherapy for Bone and Soft Tissue Tumors.
    Takakusagi Y; Koge H; Kano K; Shima S; Tsuchida K; Mizoguchi N; Yoshida D; Kamada T; Katoh H
    Anticancer Res; 2023 Jun; 43(6):2777-2781. PubMed ID: 37247930
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Type 2 Diabetes Mellitus and Efficacy outcomes from Immune Checkpoint Blockade in Patients with Cancer.
    Cortellini A; D'Alessio A; Cleary S; Buti S; Bersanelli M; Bordi P; Tonini G; Vincenzi B; Tucci M; Russo A; Pantano F; Russano M; Stucci LS; Sergi MC; Falconi M; Zarzana MA; Santini D; Spagnolo F; Tanda ET; Rastelli F; Giorgi FC; Pergolesi F; Giusti R; Filetti M; Lo Bianco F; Marchetti P; Botticelli A; Gelibter A; Siringo M; Ferrari M; Marconcini R; Vitale MG; Nicolardi L; Chiari R; Ghidini M; Nigro O; Grossi F; De Tursi M; Di Marino P; Queirolo P; Bracarda S; Macrini S; Inno A; Zoratto F; Veltri E; Spoto C; Vitale MG; Cannita K; Gennari A; Morganstein DL; Mallardo D; Nibid L; Sabarese G; Brunetti L; Perrone G; Ascierto PA; Ficorella C; Pinato DJ
    Clin Cancer Res; 2023 Jul; 29(14):2714-2724. PubMed ID: 37125965
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. The expression of programmed death-ligand 1 and programmed death-ligand 2 in endometrial carcinosarcoma: Correlation with mismatch repair protein expression status, tumor-infiltrating lymphocyte infiltration, and clinical outcomes.
    Atılgan AO; Tepeoğlu M; Özen Ö; Reyhan ANH; Ayhan A
    Ann Diagn Pathol; 2023 Aug; 65():152137. PubMed ID: 37060883
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Neurosurgical management of proton beam therapy-induced moyamoya syndrome.
    Zhang CH; Muirhead W; Silva AHD; Toolis C; Robertson F; Rennie A; Bhate S; Thompson DNP; Ganesan V; James G
    J Neurosurg Pediatr; 2023 Apr; 31(4):369-379. PubMed ID: 36738468
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. PAX-FOXO1 fusion status in children and adolescents with alveolar rhabdomyosarcoma: Impact on clinical, pathological, and survival features.
    Raze T; Lapouble E; Lacour B; Guissou S; Defachelles AS; Gaspar N; Delattre O; Pierron G; Desandes E
    Pediatr Blood Cancer; 2023 Apr; 70(4):e30228. PubMed ID: 36722003
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Intralesional curettage and cementation of low-grade chondrosarcomas of the appendicular skeleton: Long-term results from a single center.
    Görgün B; Özşahin MK; Tok O; Davulcu CD; Karaismailoğlu B; Hız M
    Acta Orthop Traumatol Turc; 2022 Nov; 56(6):402-407. PubMed ID: 36567544
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Extraskeletal myxoid chondrosarcoma: p53 and Ki-67 offer prognostic value for clinical outcome - an immunohistochemical and molecular analysis of 31 cases.
    Giner F; López-Guerrero JA; Machado I; Rubio-Martínez LA; Espino M; Navarro S; Agra-Pujol C; Ferrández A; Llombart-Bosch A
    Virchows Arch; 2023 Feb; 482(2):407-417. PubMed ID: 36376703
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Intercalary frozen autografts for reconstruction of bone defects following meta-/diaphyseal tumor resection at the extremities.
    Yang J; Li W; Feng R; Li D
    BMC Musculoskelet Disord; 2022 Sep; 23(1):890. PubMed ID: 36180843
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. clinical outcomes of Scanning Carbon-ion Radiotherapy for Soft Tissue Sarcoma of the Extremities.
    Takakusagi Y; Serizawa I; Koge H; Kano K; Shima S; Tsuchida K; Mizoguchi N; Yoshida D; Katoh H; Hiruma T; Kamada T
    Anticancer Res; 2022 Jul; 42(7):3701-3706. PubMed ID: 35790269
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Thoracic Epithelioid Hemangioendothelioma: clinical demonstration and therapeutic procedures.
    Graça LL; Almeida Cunha S; Lopes RS; Carvalho L; Prieto D
    Port J Card Thorac Vasc Surg; 2022 Jul; 29(2):39-44. PubMed ID: 35780414
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. clinical outcome Following Prolonged Neoadjuvant Chemotherapy and Delayed Surgery in Osteosarcoma Patients: An Evidence-based clinical Review.
    Sugito W; Kamal AF
    Acta Med Indones; 2022 Jan; 54(1):142-150. PubMed ID: 35398837
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Mesenchymal neoplasms of the parotid gland and parapharyngeal space: an FNA cytologic study of 22 nonlipomatous tumors.
    Wakely PE
    Cancer Cytopathol; 2022 Jun; 130(6):443-454. PubMed ID: 35195952
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. clinical outcome of paediatric ewing sarcoma and significance of pathological necrosis for mortality after neoadjuvant chemotherapy: Single institutional study.
    Sindhu II; Mehreen A; Wali RM; Abubakar M
    J Pak Med Assoc; 2021 Oct; 71(10):2344-2349. PubMed ID: 34974568
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. clinical outcome in patients who underwent amputation due to extremity soft tissue sarcoma: Tokai Musculoskeletal Oncology Consortium study.
    Hagi T; Nakamura T; Nagano A; Koike H; Yamada K; Aiba H; Fujihara N; Wasa J; Asanuma K; Kozawa E; Ishimura D; Kawanami K; Izubuchi Y; Shido Y; Sudo A; Nishida Y
    Jpn J Clin Oncol; 2022 Feb; 52(2):157-162. PubMed ID: 34875695
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Dermatofibrosarcoma protuberans. A single center retrospective experience.
    Guner M; Morkavuk SB; Unal AE
    Ann Ital Chir; 2021; 92():539-544. PubMed ID: 34795112
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. clinical Activity of Single-Agent Cabozantinib (XL184), a Multi-receptor Tyrosine Kinase Inhibitor, in Patients with Refractory Soft-Tissue sarcomas.
    O'Sullivan Coyne G; Kummar S; Hu J; Ganjoo K; Chow WA; Do KT; Zlott J; Bruns A; Rubinstein L; Foster JC; Juwara L; Meehan R; Piekarz R; Streicher H; Sharon E; Takebe N; Voth AR; Bottaro D; Costello R; Wright JJ; Doroshow JH; Chen AP
    Clin Cancer Res; 2022 Jan; 28(2):279-288. PubMed ID: 34716194
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Radiation Therapy in Primary Soft Tissue Sarcoma of the Superficial Trunk.
    Zhang M; Crago A; Yoon SS; Singer S; Alektiar K
    Ann Surg Oncol; 2022 Apr; 29(4):2316-2323. PubMed ID: 34652567
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Improving Risk Stratification for Pediatric Patients with Rhabdomyosarcoma by Molecular Detection of Disseminated Disease.
    Lak NSM; Voormanns TL; Zappeij-Kannegieter L; van Zogchel LMJ; Fiocco M; van Noesel MM; Merks JHM; van der Schoot CE; Tytgat GAM; Stutterheim J
    Clin Cancer Res; 2021 Oct; 27(20):5576-5585. PubMed ID: 34285060
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 14.